Curis Inc (NASDAQ:CRIS)
| 1.03 Delayed Data As of 3:59pm ET |  +0.055 / +5.61%Today’s Change | 0.70 Today|||52-Week Range 9.04 | -78.26% Year-to-Date |
Latest CRIS News | Press Releases
| Curis (CRIS) Q2 2022 Earnings Call Transcript Aug 05 / MotleyFool.com - Paid Partner Content | Curis (CRIS) Reports Q2 Loss, Tops Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.98 |
| Today’s open | 0.98 |
| Day’s range | 0.98 - 1.06 |
| Volume | 21,710 |
| Average volume (3 months) | 2,852,069 |
| Market cap | $91.6M |
Data as of 3:59pm ET, 08/10/2022
Growth & Valuation
| Earnings growth (last year) | +19.25% |
| Earnings growth (this year) | -36.80% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -1.72% |
| P/E ratio | NM |
| Price/Sales | 40.93 |
| Price/Book | 1.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AKTXAkari Therapeutics P... | 0.00 | 0.00% |
| SLDBSolid Biosciences In... | -0.00 | -0.13% |
| PNEXFPharnext SA | 0.00 | 0.00% |
| SEELSeelos Therapeutics ... | +0.05 | +5.59% |
Data as of 4:00pm ET, 08/10/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $10.6M |
| Annual profit (last year) | -$45.4M |
| Net profit margin | -426.67% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
